U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C36H54N12O9
Molecular Weight 798.889
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALIRINETIDE

SMILES

C[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O

InChI

InChIKey=WVPOPWDCSFQEBI-HJJAOGADSA-N
InChI=1S/C36H54N12O9/c1-20(29(51)46-26(34(56)57)10-6-16-43-36(40)41)44-32(54)27(18-22-11-13-23(50)14-12-22)47-31(53)25(9-5-15-42-35(38)39)45-33(55)28(19-49)48-30(52)24(37)17-21-7-3-2-4-8-21/h2-4,7-8,11-14,20,24-28,49-50H,5-6,9-10,15-19,37H2,1H3,(H,44,54)(H,45,55)(H,46,51)(H,47,53)(H,48,52)(H,56,57)(H4,38,39,42)(H4,40,41,43)/t20-,24-,25-,26-,27-,28-/m0/s1

HIDE SMILES / InChI

Molecular Formula C36H54N12O9
Molecular Weight 798.889
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

GM-602 (GM6) is a six-amino-acid active analog peptide of Motoneuronotrophic factor (MNTF). This compound is a small peptide that can cross the blood-brain barrier and has been shown to induce an embryonic-like neuroprotective microenvironment that helps detect and self-correct CNS- and neurodegenerative-related pathophysiology. Phase II clinical trials with GM-602, GM-604 and GM-608 have been completed to examine its potential in respectively stroke, Amyotrophic Lateral Sclerosis (ALS), and Parkinson’s disease.

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 19:16:59 GMT 2023
Edited
by admin
on Fri Dec 15 19:16:59 GMT 2023
Record UNII
6BK9OEG8CC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALIRINETIDE
INN  
Official Name English
GM-6
Code English
L-PHENYLALANYL-L-SERYL-L-ARGINYL-L-TYROSYL-L-ALANYL-L-ARGININE
Systematic Name English
(2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-AMINO-3-PHENYL-PROPANOYL)AMINO)-3-HYDROXY-PROPANOYL)AMINO)-5-GUANIDINO-PENTANOYL)AMINO)-3-(4-HYDROXYPHENYL)PROPANOYL)AMINO)PROPANOYL)AMINO)-5-GUANIDINO-PENTANOIC ACID
Systematic Name English
L-ARGININE, L-PHENYLALANYL-L-SERYL-L-ARGINYL-L-TYROSYL-L-ALANYL-
Systematic Name English
Alirinetide [WHO-DD]
Common Name English
GM-602
Code English
GM-606
Code English
GM-604
Code English
alirinetide [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 424714
Created by admin on Fri Dec 15 19:16:59 GMT 2023 , Edited by admin on Fri Dec 15 19:16:59 GMT 2023
Code System Code Type Description
FDA UNII
6BK9OEG8CC
Created by admin on Fri Dec 15 19:16:59 GMT 2023 , Edited by admin on Fri Dec 15 19:16:59 GMT 2023
PRIMARY
CAS
725715-18-4
Created by admin on Fri Dec 15 19:16:59 GMT 2023 , Edited by admin on Fri Dec 15 19:16:59 GMT 2023
PRIMARY
NCI_THESAURUS
C166924
Created by admin on Fri Dec 15 19:16:59 GMT 2023 , Edited by admin on Fri Dec 15 19:16:59 GMT 2023
PRIMARY
PUBCHEM
9875671
Created by admin on Fri Dec 15 19:16:59 GMT 2023 , Edited by admin on Fri Dec 15 19:16:59 GMT 2023
PRIMARY
INN
10615
Created by admin on Fri Dec 15 19:16:59 GMT 2023 , Edited by admin on Fri Dec 15 19:16:59 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Originator: CancerVax Corporation; Class: Cancer vaccine; Mechanism of Action: Immunostimulant; Orphan Drug Status: No; On Fast track: No; Highest Development Phase: Discontinued for Colorectal cancer, Malignant melanoma; Most Recent Events: 05 Oct 2005 Discontinued - Phase-III for Malignant melanoma in New Zealand(Intradermal), 05 Oct 2005 Discontinued - Phase-III for Malignant melanoma in Europe (Intradermal), 05 Oct 2005 Discontinued - Phase-III for Malignant melanoma in Australia (Intradermal)